Low Blood Pressure News and Research

RSS

Hypotension is low blood pressure. Blood pressure is the force of blood pushing against the walls of the arteries as the heart pumps out blood. Blood pressure is measured as systolic and diastolic pressures. Systolic blood pressure is the pressure when the heart beats while pumping blood. Diastolic blood pressure is the pressure when the heart is at rest between beats. You will most often see blood pressure numbers written with the systolic number above or before the diastolic, such as 120/80 mmHg. (The mmHg is millimeters of mercury-the units used to measure blood pressure.) Normal blood pressure in adults is lower than 120/80 mmHg. Hypotension is blood pressure that's lower than 90/60 mmHg.

Healthy diet may not counteract effects of high salt intake on blood pressure, study suggests

A healthy diet may not offset the effects of a high salt intake on blood pressure, suggests a new study.

5 Mar 2018

Mitochondrial impairment may actually protect the brain in Parkinson's disease, study shows

A Norwegian study shows that impairment in mitochondria may actually protect the brain in Parkinson's disease.

15 Jan 2018

FDA approves drug to increase blood pressure in adults with septic or distributive shock

The U.S. Food and Drug Administration today approved Giapreza (angiotensin II) injection for intravenous infusion to increase blood pressure in adults with septic or other distributive shock.

21 Dec 2017

VICC selected to administer FDA-approved CAR T therapy for treatment of lymphoma patients

Vanderbilt-Ingram Cancer Center has been selected as one of the few authorized treatment centers in the United States approved to administer the first FDA- approved chimeric antigen receptor T cell (CAR T) therapy for treatment of adult patients with a specific type of lymphoma.

25 Oct 2017

New CAR-T cell therapy offers effective option for certain blood cancer patients

Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis is one of the first centers nationwide to offer a new immunotherapy that targets certain blood cancers.

19 Oct 2017

Doctors and older patients should work together to dial back diabetes treatment, study suggests

Anyone with diabetes who takes blood sugar medication knows their doctor prescribed it to help them. After all, the long-term effects of elevated blood sugar can harm everything from the heart and kidneys to the eyes and feet.

15 Sep 2017

FDA makes the first gene therapy Kymriah available for treatment of pediatric ALL

The U.S. Food and Drug Administration (FDA) has issued a press release making the first even gene therapy available for treatment of children with a form of acute lymphoblastic leukemia (ALL).

30 Aug 2017

$Novartis gets FDA approval for novel immunocellular therapy to treat relapsed or refractory B-cell ALL$

Novartis gets FDA approval for novel immunocellular therapy to treat relapsed or refractory B-cell ALL

Novartis announced today that the US Food and Drug Administration has approved Kymriah (tisagenlecleucel) suspension for intravenous infusion, formerly CTL019, the first chimeric antigen receptor T cell (CAR-T) therapy, for the treatment of patients up to 25 years of age with B-cell precursor acute lymphoblastic leukemia (ALL) that is refractory or in second or later relapse.

30 Aug 2017

FDA approves first cell-based gene therapy for use in the United States

The U.S. Food and Drug Administration issued a historic action today making the first gene therapy available in the United States, ushering in a new approach to the treatment of cancer and other serious and life-threatening diseases.

30 Aug 2017

Biomedical engineering researchers aim to attack two banes of cardiovascular disease

Biomedical engineering researchers will attack two banes of cardiovascular disease -; heart failure after heart attacks and the scourge of resistant high blood pressure -; with $4.8 million in National Institutes of Health grants that begin this fall.

26 Aug 2017

Study recommends revision of current guidelines for assessing orthostatic hypotension

A new study led by Johns Hopkins researchers suggests that testing for the presence of orthostatic hypotension, a form of low blood pressure, be performed within one minute of standing after a person has been lying down.

31 Jul 2017

Researchers find uncertainty in accuracy of blood pressure measurements

A comprehensive analysis of blood pressure data from the 1950s to the present day has highlighted the need for improvement in the accuracy of blood pressure measuring.

26 Jul 2017

Aggressive treatment for hypertension may lead to kidney damage, research suggests

Aggressive combination treatments for high blood pressure that are intended to protect the kidneys may actually be damaging the organs, new research from the University of Virginia School of Medicine suggests.

18 Jul 2017

FDA panel recommends new breakthrough gene therapy for B-cell acute lymphoblastic leukemia (ALL)

A Food and Drug Administration (FDA) panel created history by recommending a gene therapy for patients with cancer. In this therapy the patient’s own genes would be modified to fight the cancer cells. The patient’s cells which are thus altered to treat the cancer would thus be termed as “living drugs” as they act as soldiers to treat the cancer. These cells boost up the immune system and help the body fight the cancer.

14 Jul 2017

UAB emergency medicine physician offers tips to deal with snakebite

Allison Davis never saw the snake. The Mountain Brook, Alabama, elementary school teacher was pulling weeds from a planter on her deck when she felt a sharp stab of pain in her left hand.

9 Jun 2017

New immunotherapy sends multiple myeloma into remission

Researchers are reporting the impressive results of a new cell and gene therapy that has achieved unprecedented success in treating multiple myeloma patients. Although the study is an early one and the population only included 35 people, every one of the patients responded to the treatment and 33 (94%) were in some degree of clinical remission within two months.

6 Jun 2017

Combining oral drug with personalized cell therapy can lead to complete remission in CLL patients

Combining the kinase inhibitor ibrutinib with an investigational personalized cellular therapy known as CTL119 can lead to complete remission in patients with high-risk chronic lymphocytic leukemia (CLL), according to new research from the Perelman School of Medicine at the University of Pennsylvania and Penn's Abramson Cancer Center

31 May 2017

Clinical study tests 100-year-old drug in children with autism spectrum disorder

In a small, randomized Phase I/II clinical trial (SAT1), researchers at University of California San Diego School of Medicine say a 100-year-old drug called suramin, originally developed to treat African sleeping sickness, was safely administered to children with autism spectrum disorder (ASD), who subsequently displayed measurable, but transient, improvement in core symptoms of autism.

26 May 2017

Study: Angiotensin II can safely improve blood pressure among critically ill patients with hypotension

Sixty years after Cleveland Clinic researchers first isolated the role of angiotensin II in controlling blood pressure, a new international study led by Cleveland Clinic researchers shows that the compound can safely improve blood pressure among critically ill patients who are experiencing life-threatening hypotension, or low blood pressure.

22 May 2017

Researchers develop new test for rapid and reliable diagnosis of sepsis

Researchers have developed a test that can rapidly and reliably diagnose sepsis, a potentially life-threatening complication of bacterial infections.

17 May 2017

Low Blood Pressure News and Research

Further Reading

Healthy diet may not counteract effects of high salt intake on blood pressure, study suggests

Mitochondrial impairment may actually protect the brain in Parkinson's disease, study shows

FDA approves drug to increase blood pressure in adults with septic or distributive shock

VICC selected to administer FDA-approved CAR T therapy for treatment of lymphoma patients

New CAR-T cell therapy offers effective option for certain blood cancer patients

Doctors and older patients should work together to dial back diabetes treatment, study suggests

FDA makes the first gene therapy Kymriah available for treatment of pediatric ALL

Novartis gets FDA approval for novel immunocellular therapy to treat relapsed or refractory B-cell ALL

FDA approves first cell-based gene therapy for use in the United States

Biomedical engineering researchers aim to attack two banes of cardiovascular disease

Study recommends revision of current guidelines for assessing orthostatic hypotension

Researchers find uncertainty in accuracy of blood pressure measurements

Aggressive treatment for hypertension may lead to kidney damage, research suggests

FDA panel recommends new breakthrough gene therapy for B-cell acute lymphoblastic leukemia (ALL)

UAB emergency medicine physician offers tips to deal with snakebite

New immunotherapy sends multiple myeloma into remission

Combining oral drug with personalized cell therapy can lead to complete remission in CLL patients

Clinical study tests 100-year-old drug in children with autism spectrum disorder

Study: Angiotensin II can safely improve blood pressure among critically ill patients with hypotension

Researchers develop new test for rapid and reliable diagnosis of sepsis

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News